0
0
In a significant development, AstraZeneca has admitted for the first time in court documents that its Covid-19 vaccine may lead to a rare side effect. The admission comes amidst an ongoing class-action lawsuit alleging serious injuries and deaths resulting from the AstraZeneca vaccine, sold globally under various brand names.
The Oxford–AstraZeneca Covid vaccine, known as Covishield and Vaxzevria among others, has been at the forefront of the global vaccination effort. However, the pharmaceutical giant now faces legal challenges as families allege devastating side effects from the vaccine.
The lawsuit, initiated by Jamie Scott and others, highlights the severe impact of a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS), characterized by blood clots and low platelet counts. Scott, who suffered a permanent brain injury after receiving the AstraZeneca vaccine in April 2021, is among those seeking justice through legal action.
In a crucial turn of events, AstraZeneca has conceded in legal documents submitted to the UK High Court that its vaccine “can, in very rare cases, cause TTS.” This admission marks a pivotal moment in the ongoing legal battle, shedding light on the potential risks associated with vaccination.
While AstraZeneca acknowledges the rare side effect, it contests claims of widespread vaccine defects or overstatement of efficacy. The company’s admission could have significant implications, potentially leading to substantial payouts if vaccine-induced illness or death is acknowledged in specific cases.
It’s worth noting that the AstraZeneca-Oxford vaccine is no longer administered in the UK due to safety concerns, although independent studies have demonstrated its effectiveness in combating the pandemic. The emergence of rare side effects has prompted regulatory scrutiny and legal action globally.
As legal proceedings unfold, affected individuals and their families advocate for fair compensation and acknowledgment of vaccine-induced injuries. The admission by AstraZeneca underscores the importance of transparency and accountability in addressing concerns related to Covid-19 vaccination.
